Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/6160 stock hub

HKG/6160 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/6160is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

271.6B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/6160

In the news

Latest news · HKG/6160

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E42.7

P25 11.7P50 18.9P75 41.4

Trailing P/E67.5

P25 10.7P50 17.9P75 38.5

ROE12.4

P25 -14.7P50 2P75 9.4

ROIC53.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/6160 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	HK
Employees	12,000
Employees Change	1,000%
Employees Change Percent	9.09
Enterprise value	HKD 243.1B
Exchange	Hong Kong Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG1146Y1017
Last refreshed	2026-05-10
Market cap	HKD 271.6B
Price	HKD 191
Price currency	HKD
Rev Per Employee	3,749,629.35x
Sector	Healthcare
Sic	2836
Symbol	hkg/6160
Website	https://beonemedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.48%
EV Earnings	60.45x
EV/EBIT	45.38x
EV/EBITDA	36.37x
EV/FCF	27.82x
EV/Sales	5.41x
FCF yield	3.22%
Forward P/E	42.67x
P/B ratio	7.28x
P/E ratio	67.54x
P/S ratio	6.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.95%
EBITDA Margin	14.38%
FCF margin	19.42%
Gross margin	88.31%
Gross Profit	HKD 39.7B
Gross Profit Growth	43.11%
Gross Profit Growth Q	41.37%
Gross Profit Growth3 Y	45.54%
Net Income	HKD 4B
Net Income Growth Q	17,802.13%
Net Income Growth Quarters	5%
Net Income Growth Years	3%
Pretax Margin	11.42%
Profit Margin	8.94%
Profit Per Employee	HKD 335,175
Profitable Years	1
ROA	5.96
Roa5y	-8.44
ROCE	10.17
ROE	12.42
Roe5y	-20.17
ROIC	53.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	35.21%
Cagr3y	7.23%
Cagr5y	0.48%
EPS Growth Q	16,970.8
EPS Growth Quarters	5
EPS Growth Years	3
OCF Growth	505.99%
OCF Growth Q	356.73%
Revenue Growth	37.44x
Revenue Growth Q	35.46x
Revenue Growth Quarters	15x
Revenue Growth Years	5x
Revenue Growth3 Y	54.47x
Revenue Growth5 Y	46.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.8
Assets	HKD 67.1B
Cash	HKD 37.6B
Current Assets	HKD 51.7B
Current Liabilities	HKD 14.2B
Debt	HKD 9B
Debt EBITDA	HKD 1.34
Debt Equity	HKD 0.24
Debt FCF	HKD 1.03
Equity	HKD 37.3B
Interest Coverage	8.15
Liabilities	HKD 29.7B
Long Term Assets	HKD 15.4B
Long Term Liabilities	HKD 15.6B
Net Cash	HKD 28.6B
Net Cash By Market Cap	HKD 10.51
Net Cash Growth	139.72%
Net Debt EBITDA	HKD -4.41
Net Debt Equity	HKD -0.77
Net Debt FCF	HKD -3.27
Tangible Book Value	HKD 36.8B
Tangible Book Value Per Share	HKD 332
WACC	6.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.64
Inventory Turnover	1.14
Net Working Capital	HKD 1.1B
Quick ratio	3.17
Working Capital	HKD 37.6B
Working Capital Turnover	HKD 13.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	35.18%
200-day SMA	191.7
3Y total return	23.29%
50-day SMA	181.8
50-day SMA vs 200-day SMA	50under200
5Y total return	2.42%
All Time High	278.6
All Time High Change	-31.59%
All Time High Date	2021-09-17
All Time Low	61.05
All Time Low Change	212.2%
All Time Low Date	2018-10-26
ATR	6.35
Beta	0.5
Ch YTD	6.3
High	194.3
High52	229.4
High52 Date	2025-11-13
High52ch	-16.91%
Low	189.6
Low52	125.1
Low52 Date	2025-05-12
Low52ch	52.36%
Ma50ch	4.82%
Price vs 200-day SMA	-0.57%
RSI	59
RSI Monthly	56.92
RSI Weekly	51.03
Sharpe ratio	0.69x
Sortino ratio	1.15
Total Return	-8.16%
Tr YTD	6.3
Tr1m	1.65%
Tr1w	7.87%
Tr3m	-7.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 5.4B
Operating Income Growth Q	2,151
Operating margin	11.95

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,053,286%
Net Borrowing	1,186,479,825
Shares Qo Q	0.34%
Shares Yo Y	8.16%
Short Ratio	4.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 4.5B
Average Volume	3,477,368.15x
Bv Per Share	335.9
CAPEX	HKD -1.3B
Ch1m	1.65
Ch1w	7.87
Ch1y	35.18
Ch3m	-7.12
Ch3y	23.29
Ch5y	2.42
Ch6m	0.11
Change	0.9%
Change From Open	0.37
Close	188.9
Days Gap	0.53
Depreciation Amortization	1,096,589,294.1
Dollar Volume	1,150,144,441.6
Earnings Date	2026-04-15
EBIT	HKD 5.4B
EBITDA	HKD 6.5B
EPS	HKD 34.53
F Score	7
FCF	HKD 8.7B
FCF EV Yield	3.59x
Financing CF	9,109,040,493
Fiscal Year End	December
Founded	2,010
Graham Number	510.83272
Graham Upside	168
Income Tax	HKD 1.1B
Investing CF	-1,565,846,146
Is Primary Listing	1
Last Earnings Date	2026-04-15
Last Report Date	2026-03-31
Ma150	192.9
Ma150ch	-1.2%
Ma20	185
Ma20ch	3.01%
Net CF	18,211,134,702
Next Earnings Date	2026-08-31
Open	189.9
P FCF Ratio	31.09
P OCF Ratio	26.97
Position In Range	21.28
Ppne	13,990,398,393.2
Price Date	2026-05-08
Price EBITDA	HKD 41.98
Ptbv Ratio	7.37
Relative Volume	1.77x
Revenue	44,995,552,240x
SBC By Revenue	9.39x
Share Based Comp	4,223,701,497
Tax By Revenue	2.48x
Tax Rate	21.7%
Tr6m	0.11%
Volume	6,034,336
Z Score	5.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/6160 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/6160 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/6160?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HKG/6160 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.0

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/6160

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/6160 stock rating?

hkg/6160 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/6160 analysis?

The full report lives at /stocks/hkg/6160/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/6160?

The latest report frames hkg/6160 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/6160 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.